328 related articles for article (PubMed ID: 18395381)
1. [New use of primaquine for malaria].
Oliver M; Simon F; de Monbrison F; Beavogui AH; Pradines B; Ragot C; Moalic JL; Rapp C; Picot S
Med Mal Infect; 2008 Apr; 38(4):169-79. PubMed ID: 18395381
[TBL] [Abstract][Full Text] [Related]
2. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I.
Hill DR; Baird JK; Parise ME; Lewis LS; Ryan ET; Magill AJ
Am J Trop Med Hyg; 2006 Sep; 75(3):402-15. PubMed ID: 16968913
[TBL] [Abstract][Full Text] [Related]
3. Primaquine therapy for malaria.
Baird JK; Hoffman SL
Clin Infect Dis; 2004 Nov; 39(9):1336-45. PubMed ID: 15494911
[TBL] [Abstract][Full Text] [Related]
4. Problems in the therapy for imported malaria in the United States.
Singh K; Wester WC; Trenholme GM
Arch Intern Med; 2003 Sep; 163(17):2027-30. PubMed ID: 14504115
[TBL] [Abstract][Full Text] [Related]
5. Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.
Shanks GD; Kain KC; Keystone JS
Clin Infect Dis; 2001 Aug; 33(3):381-5. PubMed ID: 11438908
[TBL] [Abstract][Full Text] [Related]
6. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
Schwartz E; Regev-Yochay G
Clin Infect Dis; 1999 Dec; 29(6):1502-6. PubMed ID: 10585803
[TBL] [Abstract][Full Text] [Related]
7. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
[TBL] [Abstract][Full Text] [Related]
8. Primaquine for prevention of malaria in travelers.
Baird JK; Fryauff DJ; Hoffman SL
Clin Infect Dis; 2003 Dec; 37(12):1659-67. PubMed ID: 14689349
[TBL] [Abstract][Full Text] [Related]
9. Compliance to recommendations for the management of curative treatment of Plasmodium vivax/ovale infections.
Faucher JF; Bellanger AP; Shaniya N; Hustache-Mathieu L; Hoen B; Chirouze C
Med Mal Infect; 2014 Aug; 44(8):387-9. PubMed ID: 25015307
[TBL] [Abstract][Full Text] [Related]
10. Relapses of vivax malaria after a conventional course of primaquine and chloroquine: report of 2 cases.
Charoenlarp P; Harinasuta T
Southeast Asian J Trop Med Public Health; 1973 Mar; 4(1):135-7. PubMed ID: 4577922
[No Abstract] [Full Text] [Related]
11. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers.
Soto J; Toledo J; Rodriquez M; Sanchez J; Herrera R; Padilla J; Berman J
Clin Infect Dis; 1999 Jul; 29(1):199-201. PubMed ID: 10433587
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
[TBL] [Abstract][Full Text] [Related]
13. Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
Edstein MD; Walsh DS; Eamsila C; Sasiprapha T; Nasveld PE; Kitchener S; Rieckmann KH
Med Trop (Mars); 2001; 61(1):56-8. PubMed ID: 11584657
[TBL] [Abstract][Full Text] [Related]
14. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
Wells TN; Burrows JN; Baird JK
Trends Parasitol; 2010 Mar; 26(3):145-51. PubMed ID: 20133198
[TBL] [Abstract][Full Text] [Related]
15. Primaquine revisited six decades after its discovery.
Vale N; Moreira R; Gomes P
Eur J Med Chem; 2009 Mar; 44(3):937-53. PubMed ID: 18930565
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy.
Goller JL; Jolley D; Ringwald P; Biggs BA
Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026
[TBL] [Abstract][Full Text] [Related]
17. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
Carmona-Fonseca J; Alvarez G; Maestre A
Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
19. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
[TBL] [Abstract][Full Text] [Related]
20. Primaquine for radical cure of Plasmodium vivax and Plasmodium ovale malaria: an observational survey (2008-2010).
Faucher JF; Bellanger AP; Chirouze C; Hustache-Mathieu L; Genton S; Hoen B
J Travel Med; 2013; 20(2):134-6. PubMed ID: 23464724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
